Fayez Sarofim & Co’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$289K Hold
2,300
﹤0.01% 277
2025
Q1
$315K Hold
2,300
﹤0.01% 267
2024
Q4
$352K Hold
2,300
﹤0.01% 256
2024
Q3
$446K Hold
2,300
﹤0.01% 229
2024
Q2
$533K Hold
2,300
﹤0.01% 211
2024
Q1
$496K Hold
2,300
﹤0.01% 216
2023
Q4
$554K Hold
2,300
﹤0.01% 206
2023
Q3
$591K Hold
2,300
﹤0.01% 200
2023
Q2
$655K Sell
2,300
-5,113
-69% -$1.46M ﹤0.01% 188
2023
Q1
$2.06M Hold
7,413
0.01% 145
2022
Q4
$2.05M Hold
7,413
0.01% 139
2022
Q3
$1.98M Hold
7,413
0.01% 138
2022
Q2
$1.51M Sell
7,413
-315
-4% -$64.2K 0.01% 161
2022
Q1
$1.63M Sell
7,728
-2,300
-23% -$485K 0.01% 170
2021
Q4
$2.41M Hold
10,028
0.01% 154
2021
Q3
$2.84M Hold
10,028
0.01% 139
2021
Q2
$3.47M Hold
10,028
0.01% 132
2021
Q1
$2.81M Sell
10,028
-1,520
-13% -$425K 0.01% 134
2020
Q4
$2.83M Hold
11,548
0.01% 130
2020
Q3
$3.28M Buy
11,548
+1,470
+15% +$417K 0.01% 116
2020
Q2
$2.7M Buy
10,078
+30
+0.3% +$8.03K 0.01% 124
2020
Q1
$3.18M Hold
10,048
0.02% 109
2019
Q4
$2.98M Buy
10,048
+315
+3% +$93.5K 0.01% 126
2019
Q3
$2.27M Hold
9,733
0.01% 127
2019
Q2
$2.28M Sell
9,733
-6,668
-41% -$1.56M 0.01% 128
2019
Q1
$3.88M Buy
16,401
+6,668
+69% +$1.58M 0.02% 117
2018
Q4
$2.93M Hold
9,733
0.02% 116
2018
Q3
$3.44M Hold
9,733
0.02% 116
2018
Q2
$2.83M Hold
9,733
0.02% 116
2018
Q1
$2.67M Buy
9,733
+20
+0.2% +$5.48K 0.01% 116
2017
Q4
$3.09M Hold
9,713
0.02% 113
2017
Q3
$3.04M Hold
9,713
0.02% 115
2017
Q2
$2.64M Hold
9,713
0.01% 118
2017
Q1
$2.66M Hold
9,713
0.01% 120
2016
Q4
$2.75M Hold
9,713
0.02% 121
2016
Q3
$3.04M Hold
9,713
0.02% 121
2016
Q2
$2.35M Buy
9,713
+5,000
+106% +$1.21M 0.01% 125
2016
Q1
$1.23M Hold
4,713
0.01% 139
2015
Q4
$1.44M Buy
4,713
+113
+2% +$34.6K 0.01% 133
2015
Q3
$1.34M Hold
4,600
0.01% 133
2015
Q2
$1.86M Hold
4,600
0.01% 120
2015
Q1
$1.94M Hold
4,600
0.01% 121
2014
Q4
$1.56M Hold
4,600
0.01% 132
2014
Q3
$1.52M Hold
4,600
0.01% 131
2014
Q2
$1.45M Hold
4,600
0.01% 136
2014
Q1
$1.41M Hold
4,600
0.01% 134
2013
Q4
$1.29M Buy
+4,600
New +$1.29M 0.01% 139
2013
Q2
$990K Buy
+4,600
New +$990K 0.01% 141